中国急性缺血性脑卒中早期血管内介入诊疗指南2018  

Chinese guidelines for the endovascular treatment of acute ischemic stroke 2018

作　　者：中华医学会神经病学分会 中华医学会神经病学分会脑血管病学组 中华医学会神经病学分会神经血管介入协作组 刘新峰[2] 刘鸣[3] 崔丽英[4] Chinese Society of Neurology;Chinese Stroke Society;Neurovascular Intervention Group of Chinese Society of Neurology

机构地区：[1]不详 [2]南京军区南京总医院神经内科,210002 [3]四川大学华西医院神经内科,成都610041 [4]中国医学科学院北京协和医院神经科,100730

出　　处：《中华神经科杂志》2018年第9期683-691,共9页Chinese Journal of Neurology

摘　　要：中华医学会神经病学分会及其脑血管病学组和神经血管介入协作组，组织相关专家在2015年《中国急性缺血性脑卒中早期血管内介入诊疗指南》的基础上，结合近3年来相关的循证医学证据和我国的实际情况，制订了《中国急性缺血性脑卒中早期血管内介入诊疗指南2018））。这一指南对急性缺血性脑卒中早期血管内介入治疗的适应证和禁忌证、再通方式的选择、治疗时间窗以及围手术期管理进行了广泛的更新和改写，旨在为临床实践给予规范性指导。Chinese guidelines for the endovascular treatment of acute ischemic stroke 2018 are based on the current available evidence and the realities of clinical practice in China. These guidelines supersede the 2015 guidelines. The writing members of the guidelines were appointed by the Chinese Stroke Society and Neurovascular Intervention Group of Chinese Society of Neurology. These guidelines provide an up-to-date comprehensive set of recommendations on the indications and contraindications of early endovascular treatment, recanalization strategies, therapeutic window, and postoperative management. The purpose of these guidelines is to achieve standardized guidance for the endovascular intervention for ischemic stroke.

关 键 词：脑缺血 卒中 机械取栓 血栓溶解疗法 

分 类 号：R739.41[医药卫生—肿瘤]